Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Iklé D, Villarreal M, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.
Miloslavsky EM, et al. Among authors: st clair ew.
Arthritis Rheumatol. 2014 Nov;66(11):3151-9. doi: 10.1002/art.38788.
Arthritis Rheumatol. 2014.
PMID: 25047592
Free PMC article.
Clinical Trial.